Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Microbial Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1599570

This article is part of the Research TopicAdvances of lipid metabolism in neurological diseases and mental disordersView all 11 articles

Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behavior in atherosclerotic mice by inhibiting nerve cell ferroptosis Authors:

Provisionally accepted
Peng  RenPeng Ren1Yulong  ZhaoYulong Zhao1Xue  LiXue Li1Jing  XieJing Xie1Xingxing  LiaoXingxing Liao2Qiang  LuoQiang Luo1Xu  LiuXu Liu1Jiameng  LiJiameng Li1Yuzhen  FanYuzhen Fan1Xinyi  ChengXinyi Cheng1Xinyao  FuXinyao Fu1Junjie  ZhouJunjie Zhou1Xiaoyun  WuXiaoyun Wu1*
  • 1Gannan Medical University, Ganzhou, Jiangxi Province, China
  • 2Capital Medical University, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

of co-morbidity. Baicalin (BA) can resist atherosclerosis and depression by regulating intestinal flora and host lipid metabolism. Therefore, based on intestinal microorganisms and lipid metabolism, this study explored the mechanism of baicalin against AS concomitant depression.16 C57BL/6 mice were fed with normal diet as blank control group. 48 ApoE -/-mice were randomly divided into 3 groups (model group and BAL, BAH two treatment groups). The mouse model of atherosclerosis concomitant depression was established by high-fat feeding combined with restraint stimulation for 16 weeks. Behavioral experiments and biochemical indexes were used to detect the antidepressant effect and anti-atherosclerosis effect of baicalin. Metagenomic sequencing technology combined with metabolomics analysis was used to detect the effects of BA on intestinal microflora structure and brain lipids in AS co-depressed mice. Erastin was used to induce HT-22 hippocampal neurons to construct a model of ferroptosis. The inhibition of baicalin on ferrotosis was verified by detecting the cell viability, ROS production, and expression levels of glutathione, 2 / 41 2 / 41 SLC7A11, GPX4 and ACSL4 in each group.Baicalin could effectively improve the indexes of AS co-depressed mice, and the results of metagenomics and lipidomics showed that there were disorders of intestinal flora represented by Helicobacter_typhlonius and Escherichia_coli and disorders of lipid metabolism represented by PE in the AS co-depressed model mice. The correlation analysis showed that the lipid metabolism disorders in the model mice were closely related to the intestinal flora disorders, and baicalin intervention could effectively improve the intestinal flora and lipid metabolism disorders in the AS co-depressed mice. Metabolic pathway enrichment analysis showed that differential lipid PEs were significantly enriched in the iron death pathway, and our further in vitro cellular experiments showed that baicalin could inhibit Erastin-induced Ferroptosis in the hippocampal neuronal cell line HT-22 by promoting the expression of SLC7A11, GSH, and GPX4, inhibiting the expression of ACSL4, and decreasing the cellular ROS.Baicalin improves intestinal microbiota and brain lipid metabolism and inhibits ferroptosis of nerve cells, which possesses the application value of anti-atherosclerotic concomitant depression.

Keywords: BA, Baicalin, AS, atherosclerosis, PE, phosphatidyl ethanolamine, SLC7A11, Solute carrier family 7, membrane 11, GSH, glutathione; GPX4, glutathione peroxidase 4; ACSL4, Acyl-CoA Synthetase Long Chain Family Member 4;ROS,Reactive Oxygen Species;HPA, PLS-DA, partial least-squares discrimination analysis, VIP, variable importance in the projection, TG, triglycerides, TC, total cholesterol

Received: 25 Mar 2025; Accepted: 15 Aug 2025.

Copyright: © 2025 Ren, Zhao, Li, Xie, Liao, Luo, Liu, Li, Fan, Cheng, Fu, Zhou and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiaoyun Wu, Gannan Medical University, Ganzhou, 121013, Jiangxi Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.